Mixed Early Phase III Results With Aldeyra’s First-In-Class Dry Eye Candidate

Aldeyra To Initiate Part 2 Of The Adaptive Phase III Study In 2020

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.